Tarina 24 Fe Kit
Product Images NDC 50102-224

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Tarina 24 Fe (NDC 50102-224). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Afaxys Pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-1 (Norethindroneethinyl Fig1)

A forest plot chart depicting effect estimates for studies comparing combined oral contraceptive (COC) use versus never use. It shows odds ratio (OR), hazard ratio (HR), and relative risk (RR) values with confidence intervals for several studies, including NICHD Women's Care Study, French E3N cohort, and others, with a horizontal axis labeled 'Effect Estimate' ranging from -1.50 to 2.00.*

FDA Label Image

Figure-2 (Norethindroneethinyl Fig2)

A pharmacokinetic curve showing norethindrone concentration (pg/mL) over time (hours) for Day 1 and Day 24. The graph depicts two lines: a solid line with dots for Day 1 and a dashed line with circles for Day 24, illustrating how norethindrone concentration changes in blood plasma over 60 hours.*

FDA Label Image

Figure (Norethindroneethinyl Fig3)

A line graph depicting Ethinyl Estradiol concentration (pg/mL) over time (hours) comparing Day 1 and Day 24. The x-axis represents time in hours, spanning from 0 to 60 hours, and the y-axis shows Ethinyl Estradiol concentration from 0 to 80 pg/mL. Two curves are shown: a solid line with filled circles for Day 1, and a dashed line with open circles for Day 24, illustrating concentration changes over time for each day.*

FDA Label Image

Figure4 (Norethindroneethinyl Fig4)

A chart illustrating pregnancy rates per 100 women in one year associated with various birth control methods. The vertical axis shows 'Fewer pregnancies' at the top and 'More pregnancies' at the bottom. Methods with fewer pregnancies include implants, injections, intrauterine devices, and sterilization. Moderate pregnancy rates are shown for birth control pills, skin patches, and vaginal rings with hormones. Higher pregnancy rates are associated with condoms, diaphragms, abstinence during fertile days, spermicide, and withdrawal. The highest pregnancy rate is shown for no birth control use.*

FDA Label Image

Package Label-principal Display Panel (1 mg/20 mcg Pouch Label)

An instructional diagram showing the weekly arrangement and daily directions for taking TARINA 24 FE (Norethindrone Acetate and Ethinyl Estradiol Tablets USP and Ferrous Fumarate Tablets) birth control pills. The layout includes day labels Sunday through Saturday, arrows indicating the pill-taking direction from left to right each week, and guidance for starting on Sunday or day 1 of the menstrual cycle.*

FDA Label Image

Package Label-principal Display Panel (1 mg/20 mcg Pouch Carton Label)

Packaging label for Tarina 24 Fe, a kit containing Norethindrone Acetate and Ethinyl Estradiol and Ferrous Fumarate tablets, 1 mg/20 mcg. The label indicates a 28-day regimen with 24 yellow tablets and 4 brown tablets per pouch. Manufactured by Afaxys Pharma, LLC, with NDC 50102-224-21. The label includes standard drug information and usage guidance.*

FDA Label Image

Norethindroneethinyl Fig7

Tarina 24 Fe kit packaging label for Norethindrone Acetate and Ethinyl Estradiol Tablets USP and Ferrous Fumarate Tablets, 1 mg/20 mcg, by Afaxys Pharma, LLC. The label specifies a 28-day regimen and 24 days of active therapy. The carton includes manufacturing details for Afaxys Pharma, USA, and Aurobindo Pharma Limited, India, with a barcode and NDC 50102-224-23.*

FDA Label Image

Structure-1 (Norethindroneethinyl Str1)

Chemical structure diagram showing the molecular formula of Ethinyl Estradiol, one of the active ingredients in TARINA 24 FE, a human prescription drug kit by Afaxys Pharma, LLC.*

FDA Label Image

Structure-2 (Norethindroneethinyl Str2)

Chemical structure diagram of the active ingredient Norethindrone Acetate showing its molecular configuration including rings, double bonds, and functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.